Rise of Clinical Trials Industry in India: An Analysis

Table 3

Typology of drug trials registered with CTRI.

(a) Categorization by type of sponsor

Indian public sector institution	Indian private institutions/individuals	Drug companies; (Indian & MNCs)	Foreign institutions	No sponsor/sponsor name not available
148 (32.7%)	46 (10.2%)	222 (49%)	27 (6%)	10 (2.2%)

(b) Categorization of trials by phases

Phase 1	Phase 2	Phase 3	Phase 4	Combined phase		Not* applicable
				Ph 2 & 3/Ph 3 & 4	Ph 1 & 2
18 (4%)	76 (16.8%)	161 (35.5%)	90 (19.9%)	25 (5.5%)	6 (1.3%)	77 (17%)`

(c) Categorization of trials by health conditions

Oncology	Cardiology, neurology, nephrology	Diabetes	Major infectious diseases/conditions	Common noninfectious conditions**	All other conditions***
45 (9.9%)	89 (19.6%)	62 (13.7%)	TB: 6 (1.3%); GI infections: 3 (1%); RTI: 4 (1.4%); Malaria: 4 (1.4%) (1.8%); Total: 49 (8.6%)	50 (11%)	175 (38.6%)
Public sector sponsor
6 (4%)	30 (20.3%)	14 (9.5%)	TB: 3 (2%); GI infections: 0 (0%); RTI: 1 (.7%); Malaria: 4 (2.7%); Total: 10 (6.8%)	18 (12.2%)	65 (43.9%)
Private sector sponsor
38 (12.9%)	60 (20.4%)	48 (16.3%)	TB: 2 (.7%); GI infections: 3 (1%); RTI: 4 (1.4%); Malaria: 4 (1.4%); Total: 10 (6.8%)	32 (10.8%)	109 (37%)

∗These were trials that were trying to establish clinical usage of a drug for some indications, forexample, in case of ayurvedic drugs, or were exploring new indications for drugs already in usage for other conditions. ∗∗These included painful conditions (acute and chronic asthma, dyspepsia, indigestion, conjunctivitis, sore throat, common skin conditions, reproductive tract infections, depression, etc.). ∗∗∗These included drugs used for all the other indications not covered by earlier categories.